Kelly Mayes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kelly Mayes has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anna Hart
Lancaster Medical School; University of Lancaster; Lancaster; LA1 4YB; England
1 shared publication - Colin Morgan
Neonatal Intensive Care Unit, Liverpool Women's Hospital Liverpool UK
1 shared publication - Isam Badhawi
Department of Pharmacy, Liverpool Women's Hospital, Crown St, Liverpool L8 7SS, UK
1 shared publication - Mark A. Turner
University of Liverpool, Liverpool, UK
1 shared publication - Maw Tan
Alder Hey Children’s Hospital, Liverpool L14 5AB, UK
1 shared publication - Paul Newland
Biochemistry Department, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
1 shared publication
Latest Publications
- Open Access
- 10 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 53
SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care
Infants born <29 weeks gestation are at high risk of neurocognitive disability. Early postnatal growth failure, particularly head growth, is an important and potentially reversible risk factor for impaired neurodevelopmental outcome. Inadequate nutrition is a major factor in this postnatal growth failure, optimal protein and calorie (macronutrient) intakes are rarely achieved, especially in the first week. Infants <29 weeks are dependent on parenteral nutrition for the bulk of their nutrient needs for the first 2-3 weeks of life to allow gut adaptation to milk digestion. The prescription, formulation and administration of neonatal parenteral nutrition is critical to achieving optimal protein and calorie intake but has received little scientific evaluation. Current neonatal parenteral nutrition regimens often rely on individualised prescription to manage the labile, unpredictable biochemical and metabolic control characteristic of the early neonatal period. Individualised prescription frequently fails to translate into optimal macronutrient delivery. We have previously shown that a standardised, concentrated neonatal parenteral nutrition regimen can optimise macronutrient intake.
- 10 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 53
Open AccessSCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care
Infants born <29 weeks gestation are at high risk of neurocognitive disability. Early postnatal growth failure, particularly head growth, is an important and potentially reversible risk factor for impaired neurodevelopmental outcome. Inadequate nutrition is a major factor in this postnatal growth failure, optimal protein and calorie (macronutrient) intakes are rarely achieved, especially in the first week. Infants <29 weeks are dependent on parenteral nutrition for the bulk of their nutrient needs for the first 2-3 weeks of life to allow gut adaptation to milk digestion. The prescription, formulation and administration of neonatal parenteral nutrition is critical to achieving optimal protein and calorie intake but has received little scientific evaluation. Current neonatal parenteral nutrition regimens often rely on individualised prescription to manage the labile, unpredictable biochemical and metabolic control characteristic of the early neonatal period. Individualised prescription frequently fails to translate into optimal macronutrient delivery. We have previously shown that a standardised, concentrated neonatal parenteral nutrition regimen can optimise macronutrient intake.